文献速递头颈外科

多学科肿瘤委员会对头颈癌结局的影响

The impact of the multidisciplinary tumor board on head and neck cancer outcomes.
PubMed 文献 · Laryngoscope · 2019-05-16

该回顾性队列研究纳入2006年10月至2015年5月在本机构治疗的224例头颈鳞状细胞癌(HNSCC)患者,分为多学科肿瘤委员会(MTB)前组98例和MTB后组126例。MTB后组的总生存率和疾病特异性生存率显著改善,5年疾病特异性生存率52% vs. 75%(P = .003),匹配队列分析显示MTB后组死亡风险显著降低(HR 0.48)。作者认为多学科团队治疗应被视为HNSCC的最佳实践。

要点

  • MTB后组5年疾病特异性生存率为75%,MTB前组为52%(P = .003)。
  • 匹配队列分析显示MTB后组死亡风险显著降低(HR 0.48)。
  • 作者认为多学科团队治疗应被视为HNSCC的最佳实践。

核心结论

  • 由专门的多学科团队治疗HNSCC可改善生存。
  • 多学科治疗应被视为HNSCC治疗的最佳实践。

研究设计与样本

  • 回顾性病历审查,纳入2006年10月至2015年5月在本机构治疗的HNSCC患者224例。
  • 队列分为MTB前组(2006年10月至2011年2月)98例和MTB后组(2011年2月至2015年5月)126例。
  • 进行了单因素、多因素和生存分析。

主要发现

  • 139例(62%)为黑人,91例(40%)使用医疗补助或没有保险。
  • 平均随访时间2.8年,大多数病例为晚期(68%)。
  • Kaplan-Meier评估显示,MTB后组的总生存率和疾病特异性生存率较MTB前组显著改善,5年疾病特异性生存率52% vs. 75%(P = .003)。
  • 匹配队列分析显示,MTB后组死亡风险显著降低(风险比:0.48)。

临床怎么用

  • 作者认为多学科团队治疗应被视为HNSCC治疗的最佳实践。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: Although the multidisciplinary tumor board (MTB) is accepted as best practice for the management of head and neck squamous cell carcinoma (HNSCC), there is limited evidence showing its impact on survival. Our goal was to investigate the impact of an MTB following the hiring of a fellowship-trained head and neck surgeon and implementation of an MTB at our institution. We hypothesized that these changes would demonstrate an improvement in survival. STUDY DESIGN: Retrospective chart review. METHODS: A review of HNSCC treated at our institution between October 2006 and May 2015 was performed. The cohort was divided into pre-MTB (October 2006-February 2011) and post-MTB (February 2011-May 2015) cohorts. Patient demographics, cancer stage, and treatment outcomes were reviewed. Univariate, multivariate, and survival analysis were performed. RESULTS: The study included 224 patients, 98 in the pre-MTB cohort and 126 in the post-MTB cohort. Of total patients, 139 (62%) were black and 91 (40%) were on Medicaid or uninsured. Average follow-up time was 2.8 years, and most cases were advanced stage (68%). On Kaplan-Meier evaluation, overall survival and disease-specific survival were significantly improved in the post-MTB cohort compared with the pre-MTB cohort, with a 5-year disease-specific survival of 52% vs. 75% (P = .003). A matched cohort analysis showed that the post-MTB cohort had significantly lower risk of death (hazard ratio: 0.48). CONCLUSIONS: Our study demonstrates that treatment of HNSCC by a dedicated multidisciplinary team results in improved survival. Multidisciplinary care should be considered best practice in the care of HNSCC. LEVEL OF EVIDENCE: 3b Laryngoscope, 130:946-950, 2020.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Liu JC, Kaplon A, Blackman E, et al. The impact of the multidisciplinary tumor board on head and neck cancer outcomes. Laryngoscope. 2019. PMID: 31095740. doi:10.1002/lary.28066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。